AGC Pharma Chemicals partners with AbilityPharma on pancreatic cancer treatment
Strategic partnership aims to advance ABTL0812 API from clinical trials to global patient access
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
pancreatic cancer
BioNTech, Roche’s pancreatic cancer treatment bodes well for future: Nature
Half of the trial participants had developed T cells that can potentially recognise cancerous cells and stop them from re-emerging
NATCO announces ANDA filing for generic olaparib tablets in US
Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic and prostrate cancer
LYNPARZA (olaparib) get three new approvals in Japan
Approvals in three types of cancer are based on the PAOLA-1, PROfound and POLO Phase 3 Trials
Prestige Biopharma drug gets positive EMA opinion on Orphan Designation to treat pancreatic cancer
PBP1510 has already received ODD status from the US FDA in June 2020
Scientists at University of Sheffield discover new drug to treat pancreatic cancer
The drug, which may improve life expectancy and quality for pancreatic cancer patients, was discovered after examining a hormone…
CSIR’s anti-cancer drug IIIM-290 goes into clinical trial
The clinical trial aims to assess safety, tolerability and exposure of the compound in humans along with the early efficacy…
Scientists aim to develop drugs to eliminate pancreatic cancer
The research team has carried out some preliminary studies of LXR expression in patient tumour samples and is preparing to analyse…